274 related articles for article (PubMed ID: 25449459)
1. Shexiang Tongxin dropping pill attenuates atherosclerotic lesions in ApoE deficient mouse model.
Xiong M; Jia C; Cui J; Wang P; Du X; Yang Q; Zhu Y; Wang W; Zhang T; Chen Y
J Ethnopharmacol; 2015 Jan; 159():84-92. PubMed ID: 25449459
[TBL] [Abstract][Full Text] [Related]
2. [Anti-atherosclerotic Effects of Bear Bile Powder in Shexiang Tongxin Dripping Pill: a Mechanism Study].
Xiong MQ; Jia CL; Cui JG; Ming BB; Zhu YL; Wang WJ; Chen Y; Zhang T
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1083-9. PubMed ID: 26591364
[TBL] [Abstract][Full Text] [Related]
3. Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.
Xu J; Ma C; Chen M; Rong S; Gao H; Xia Z; Huang F
Lipids Health Dis; 2018 Jul; 17(1):182. PubMed ID: 30064511
[TBL] [Abstract][Full Text] [Related]
4. Xiaoxianggou attenuates atherosclerotic plaque formation in endogenous high Ang II ApoE(-/-) mice via the inhibition of miR-203 on the expression of Ets-2 in endothelial cells.
Nie W; Zhang X; Yan H; Li S; Zhu W; Fan F; Zhu J
Biomed Pharmacother; 2016 Aug; 82():173-9. PubMed ID: 27470353
[TBL] [Abstract][Full Text] [Related]
5. Notoginsenoside R1 attenuates atherosclerotic lesions in ApoE deficient mouse model.
Jia C; Xiong M; Wang P; Cui J; Du X; Yang Q; Wang W; Chen Y; Zhang T
PLoS One; 2014; 9(6):e99849. PubMed ID: 24933211
[TBL] [Abstract][Full Text] [Related]
6. Effect of Si-Miao-Yong-An decoction on the differentiation of monocytes, macrophages, and regulatory T cells in ApoE
Chen XN; Ge QH; Zhao YX; Guo XC; Zhang JP
J Ethnopharmacol; 2021 Aug; 276():114178. PubMed ID: 33945857
[TBL] [Abstract][Full Text] [Related]
7. Suxiaojiuxin pill enhances atherosclerotic plaque stability by modulating the MMPs/TIMPs balance in ApoE-deficient mice.
Zhang J; Zhuang P; Lu Z; Zhang M; Zhang T; Zhang Y; Wang J; Liu D; Tong Y
J Cardiovasc Pharmacol; 2014 Aug; 64(2):120-6. PubMed ID: 24621651
[TBL] [Abstract][Full Text] [Related]
8. Shexiang Tongxin dropping pills protect against ischemic stroke-induced cerebral microvascular dysfunction via suppressing TXNIP/NLRP3 signaling pathway.
Zhu L; Yang YM; Huang Y; Xie HK; Luo Y; Li C; Wang W; Chen Y
J Ethnopharmacol; 2024 Mar; 322():117567. PubMed ID: 38122909
[TBL] [Abstract][Full Text] [Related]
9. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
[TBL] [Abstract][Full Text] [Related]
10. LongShengZhi Capsule Reduces Established Atherosclerotic Lesions in apoE-Deficient Mice by Ameliorating Hepatic Lipid Metabolism and Inhibiting Inflammation.
Ma J; Zhao D; Wang X; Ma C; Feng K; Zhang S; Chen Y; Zhu Y; Gao X; Zhao B; Wang Y; Qian K; Li X; Duan Y; Han J; Yang X
J Cardiovasc Pharmacol; 2019 Feb; 73(2):105-117. PubMed ID: 30540683
[TBL] [Abstract][Full Text] [Related]
11. The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
Li S; Wang K; Xu G; Ji J; Qin C
Pak J Pharm Sci; 2016 Nov; 29(6):1907-1912. PubMed ID: 28375105
[TBL] [Abstract][Full Text] [Related]
12. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.
Tian GP; Tang YY; He PP; Lv YC; Ouyang XP; Zhao GJ; Tang SL; Wu JF; Wang JL; Peng J; Zhang M; Li Y; Cayabyab FS; Zheng XL; Zhang DW; Yin WD; Tang CK
Biochem Biophys Res Commun; 2014 Jan; 443(2):428-34. PubMed ID: 24309104
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Chen ZF; Zhao B; Tang XY; Li W; Zhu LL; Tang CS; DU JB; Jin HF
Chin Med J (Engl); 2011 Nov; 124(21):3460-7. PubMed ID: 22340159
[TBL] [Abstract][Full Text] [Related]
14. Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model.
Peng L; Li M; Xu YZ; Zhang GY; Yang C; Zhou YN; Li LJ; Zhang JP
J Ethnopharmacol; 2012 Aug; 143(1):241-8. PubMed ID: 22750436
[TBL] [Abstract][Full Text] [Related]
15. Amelioration by catalpol of atherosclerotic lesions in hypercholesterolemic rabbits.
Liu JY; Zhang DJ
Planta Med; 2015 Feb; 81(3):175-84. PubMed ID: 25671384
[TBL] [Abstract][Full Text] [Related]
16. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
18. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice.
Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946
[TBL] [Abstract][Full Text] [Related]
19. Shexiang Tongxin dropping pill protects against sodium laurate-induced coronary microcirculatory dysfunction in rats.
Liu H; Zhao J; Pan S; Zhu Y; Fu G; Tang W; Peng F
J Tradit Chin Med; 2021 Feb; 41(1):89-97. PubMed ID: 33522201
[TBL] [Abstract][Full Text] [Related]
20. Shexiang Baoxin Pill Alleviates the Atherosclerotic Lesions in Mice via Improving Inflammation Response and Inhibiting Lipid Accumulation in the Arterial Wall.
Lu L; Qin Y; Zhang X; Chen C; Xu X; Yu C; Guo X
Mediators Inflamm; 2019; 2019():6710759. PubMed ID: 31379468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
